Apertus Pharmaceuticals
Apertus Pharmaceuticals

Apertus Pharmaceuticals Information

Contact top employees from Apertus Pharmaceuticals

Summary

API MANUFACTURING:
Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our...Show more

Organization Website

apertuspharma.com

Industries

Headquarters Location

331 Consort Dr., St. Louis, MO, 63011 US

Employees Size

10-50 employees

Specialties

Controlled Substance API Manufacturing (Under ICH), Analytical Methods Development and Validation, Specialty Chemical synthesis and analysis, Process Development/Improvement, Green Chemistry

Founded

2011

Employees Turnover 4 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Apertus Pharmaceuticals shows a diverse range of experience levels:
7% have been with the company for less than 1 year14% for 1–2 years7% for 3–4 years21% for 5–7 years21% for 8–10 years29% have over 11 years of service at Apertus Pharmaceuticals
Ex-employees positions
In Company
In New Company
Contact top employees from Apertus Pharmaceuticals

FAQ

Apertus Pharmaceuticals operates in the Pharma industries. More details can be found on the official website: apertuspharma.com.
The headquarters of Apertus Pharmaceuticals are located in St. Louis, United States.
Apertus Pharmaceuticals currently employs 10-50 people.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP